Bilateral temporal lobe epilepsy in a patient with Turner syndrome mosaicism  by Vulliemoz, S. et al.
Seizure (2007) 16, 261—265
www.elsevier.com/locate/yseizCASE REPORT
Bilateral temporal lobe epilepsy in a patient with
Turner syndrome mosaicism
S. Vulliemoz a,*, S. Dahoun b, M. Seeck aaDepartment of Neurology, University Hospital of Geneva, Switzerland
bDivision of Medical Genetics, University Hospital of Geneva, Switzerland
Received 7 September 2006; received in revised form 6 November 2006; accepted 13 November 2006KEYWORDS
Epilepsy;
Turner’s syndrome;
MRS;
Pharmaco-resistance;
Genetics
Summary Turner’s syndrome (TS), resulting from deletion of one X chromosome in
women, is associated with cerebral development abnormalities, particularly in the
temporal lobes. Symptomatic epilepsy is described only in cases with extensive
malformations. Here, we report the first case of bilateral temporal epilepsy without
macroscopic cerebral malformation in a woman with TS mosaicism. Bitemporal
dysfunction was confirmed by the ictal and interictal EEG, PET, MR-spectroscopy
and the neuropsychological examination, other causes than TS mosaicism were
excluded. In rare cases, TS mosaicism may underlie non-lesional temporal lobe
epilepsy, probably in relation to microanatomic structural and functional cerebral
abnormalities. Further studies are needed to determine the frequency of this
association.
# 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Turner’s syndrome (TS) results from absence of one X
chromosome inwomen (Xmonosomy). Its prevalence
is estimated to be 1 in 3000—5000 live female births.
Between 28% and 67% of TS subjects have a mosaic
pattern (TSm) where some cells have a normal chro-
mosomal set and others have only one normal X
chromosome. The phenotype, not precisely related
to the degree of monosomy, includes short stature,
webbingof theneck, gonadal dysgenesis andcoarcta-
tion of the aorta amongother vascular abnormalities.* Corresponding author at: Presurgical Evaluation Unit, Depart-
ment of Neurology, University Hospital of Geneva, Micheli-du-
Crest 24, 1211 Geneva 14, Switzerland. Tel.: +41 22 372 84 76;
fax: +41 22 372 84 75.
E-mail address: serge.vulliemoz@hcuge.ch (S. Vulliemoz).
1059-1311/$ — see front matter # 2006 British Epilepsy Association
doi:10.1016/j.seizure.2006.11.008The full neurological spectrum can include mental
retardation, psychosis and neuropsychological disor-
ders.1 The literature contains very few cases of TS
patients suffering from epilepsy,2,3 most of them
presenting with significant cortical malformation.4,5
Recently, greater attention has been directed to
the role of the X chromosome in brain development.
Several studies have focused on the particular pro-
file of cognitive functions as well as structural and
metabolic brain abnormalities in TS.6—13 Studies on
TS patients consistently point to structural and
metabolic brain abnormalities that also affect the
temporal lobe; however, to the best of our knowl-
edge, no case of temporal lobe epilepsy without
overt MRI lesion has been described.
Here, we report on a patient with late-onset
intractable bilateral non-lesional temporal lobe epi-
lepsy and X chromosome mosaic monosomy.. Published by Elsevier Ltd. All rights reserved.
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In November 2005, a 37-year-old woman was
referred for presurgical investigation of drug-resis-
tant temporal lobe epilepsy. Complex partial sei-
zures with thoracic pressure, hypersalivation,
chewing, manual automatisms and non-lateralized
dystonic posture followed by generalized tonic-
clonic seizures and ictal amnesia had started at
the age of 30 and occurred once per week with
nocturnal predominance. The disease had no cata-
menial periodicity and could not be controlled by
phenobarbital, lamotrigine, valproate, topiramate
or oxcarbazepine, either alone or in combination.
Apart from migraine without aura since her teens,
the personal history was unrevealing. The family
history revealed a healthy monozygotic twin sister
living abroad who had children. The patient herself
reported regular menstrual cycles in the past since
the age of 15. She has three healthy sons in their
teens and had had two other premature children
who had died in the neonatal period. At admission,
she was carrying a progesterone-coated intra-uter-
ine devicewith interruption ofmenstrual cycle for 2
years. The patient’s neurological examination was
normal except for absence of achillean deep tendon
reflexes. She is of normal height (162 cm) with no
dysmorphic features and normal development of
breasts and external genitalia. The neuropsycholo-
gical and psychiatric examination with a translator
disclosed significant language dysfunction and dif-
ficulties in verbal and non-verbal memory as well as
executive functions in the presence of a slight
depressive disorder. Full IQ testing could not be
carried out, given that test material was not avail-
able in her language but the patient did not appear
retarded and had attended a normal school in her
home country.
The interictal EEG showed very active bilateral
anterior temporal epileptogenic activity and slow-
ing. Six complex partial seizures (loss of conscious-
ness, chewing, manual automatisms and arm
dystonic posture with or without secondary gener-
alized seizure) were recorded, originating more
often from the left (4/6) than the right (2/6) ante-
rior temporal lobe (Fig. 1a and b). High resolution
3T MRI showed no structural abnormality. Single
voxel MR spectroscopy (MRS) revealed a diffuse
bilateral temporal decrease of the N-acetyl-aspar-
tate/choline ratio affecting both the lateral tem-
poral neocortices and the hippocampi. Concordant
with the EEGandMRS finding, interictal PET imaging
suggested a bilateral anterior temporal hypometa-
bolism (Fig. 1c).
In the context of this intractable late-onset non-
lesional epilepsy affecting both temporal lobes, anextensive work-up was carried out, including
genetic screening for mutation of mitochondrial
DNA which comprises also a chromosomal evalua-
tion. Blood tests showed normal blood cell counts,
corpuscular volume, ESR, glucose, electrolytes, pyr-
uvate, lactate, creatinine, hepatic enzymes, thyr-
oid function and serum immunoglobulins. There was
a moderate hyperammoniemia (103 mmol/l, normal
<35) when still under treatment of topiramate and
valproate. Vitamin levels were normal except for a
slightly diminished cyanocobalamine (118 pmol/l,
normal 135—700). There was an unspecific elevation
of anti-nuclear antibodies (immunofluorescence
titer 320) but rheumatoid factor, anti-nuclear anti-
bodies, anti-nucleoprotein and ANCA were nega-
tive. Antithyroid, anti-parietal cell, anti-intrinsic
factor, anti-glutamic acid decarboxylase (GAD)
and paraneoplastic antibodies were also negative.
Hormonal levels including FSH, LH, prolactin,
estradiol, progesterone, DHEA, total testosterone,
androstenedione were normal. Caryotype analysis
revealed a cell line 45, XX in 12% of analysed
cells, indicating a mosaic X monosomy. Research
for frequent mitochondrial mutations for MERFF
and MELAS (3243A > G, 3271T > C, 8344A > G,
8356T > C) was negative. A lumbar puncture
showed normal protein and cell counts and absence
of oligoclonal bands. Pelvic ultrasound was normal.
In order to rule out iatrogenic encephalopathy in
the context of a topiramate medication, this drug
was slowly removed. Five months later she was on
monotherapy of oxcarbazepine (1500 mg/d). Serum
ammonium returned to normal levels. After cessa-
tion of topiramate, the seizure frequency slightly
diminished to 3 per month. The neuropsychological
follow-up showed a clear improvement in language
and executive functions. There was no apraxia or
agnosia indicative of a parietal dysfunction. A sec-
ond MRS, performed 4 months after the first one,
showed persistent decrease of the N-acetyl-aspar-
tate/cholin ratio in both hippocampi and temporal
neocortex, indicating a stable dysfunction.Discussion
To the best of our knowledge, this is the first pub-
lished case of TSm associated with non-lesional
bilateral temporal lobe epilepsy. Even though the
amount of monosomic blood cells is low (12%), the
two conditions may be causally related, for the
reasons we will outline below.
The X chromosome is strongly implicated in
cerebral development. X-linked cerebral malforma-
tion syndromes include periventricular hetero-
topia, polymicrogyria and lissencephaly. TS-linked
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Figure 1 (a) Ictal EEG: right temporal seizure onset; (b) ictal EEG: left temporal seizure onset; (c) interictal PET
showing a bilateral anterior temporal hypometabolism affecting both the hippocampi and neocortices (arrows).
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phy,4 and extensive polymicrogyria.5 Rare autopsy
descriptions have disclosed mild cortical dysplasia
with subcortical heterotopia.14,15 Volumetric MRI
studies consistently report global and local volume
differences in TS subjects compared to normal sub-
jects. Differences were noted in the gray or white
matter of the temporal lobes,6,7,9,12 as well as the
amygdalo-hippocampal structures,8,10 in a sym-
metric or asymmetric pattern. TSm patients have
a temporal lobe volume between that of normal
subjects and full TS patients.10 These observations
point to an abnormal cellular density and connec-
tivity in the mesial and lateral aspects of temporal
lobes in TS and probably also TSm subjects. The
impact of an abnormal X chromosome is further
exemplified by MRI studies in patients with other
X chromosome syndromes. Patients with premuta-
tions of fragile-X syndrome showed an increased
volume of the amygdalo-hippocampal structures,16
while subjects with Klinefelter syndrome (47, XXY)
showed a reduction in temporal grey matter,17 thus
underlining the major impact of the X chromosome
on the development of temporal lobe structures.
MR-spectroscopy is an established technique to
reveal subtle structural abnormalities in patients
with MRI-negative temporal lobe epilepsy.18 Bilat-
eral low N-acetyl-aspartate-related metabolic
ratios were found in patients with full TS.6,12 Con-
sistent with these reports, our patient had abnor-
mally lowmetabolites in the temporal regions in two
consecutive scans, performed 4 months apart, pre-
sumably reflecting subtle, persistent abnormalities
in both mesial and lateral temporal lobe structures.
Histopathological studies on patients with MRI-
negative epilepsy found discrete abnormalities,
i.e. hippocampal sclerosis, microdysgenesis or focal
cortical dysplasia,19 indicating that epileptogenic
lesions might be present with a normal MRI.
Reports on epilepsy in TS are extremely rare.
Epilepsy is mostly described as symptomatic of
developmental malformation seen on the MRI in
some cases.4,5 One earlier EEG study showed epi-
leptogenic activity in 1 of 64 TS patients, suggestive
of idiopathic epilepsy, but without radiological doc-
umentation.3 In a more recent study, no epilepti-
form activity was noted in 11 subjects with TS (2
with TSm).2 However, the study type appeared to be
of observational character, given that patients were
recorded because of the presence of a chromosomal
disorder. To the best of our knowledge, no study on
the prevalence of chromosomal abnormalities in
patients with pharmaco-resistant epilepsy has been
done, thus we do not know how many patients seen
in tertiary epilepsy centres present additional
genetic abnormalities, including TSm.The role of hormonal insufficiency (estrogens and
androgens) appears to be relevant inmany abnormal
neurological, reproductive and neuropsychological
conditions, including TS and also epilepsy.20 While
there was evidence for neurological and neuropsy-
chological impairment, there was no indication of a
reproductive disorder. Our patient has healthy chil-
dren, and a gynecological and endocrinological
work-up was normal, as can be seen in TSm and
even in some full TS subjects.21 There was no asso-
ciation between the seizure frequency and the
menstrual cycle nor any modification induced by
the progesterone-coated intra-uterine device.
Therefore, there is no argument for a significant,
direct hormonal influence on the bitemporal sei-
zures in our patient; however, subtle changes exert-
ing a non-cyclic effect cannot be ruled out.
The patient’s twin sister, reportedly monozygo-
tic, does not suffer from epilepsy. While we could
not perform genetic testing in the sister, she should
have a normal caryotype 46, XX without mosaicism,
since the mosaic TS results from post-meiotic dis-
turbances. Thus, the presence of the fertile and
non-epileptic monozygotic twin does not speak
against the association between epilepsy and
mosaic TS.
Even if causality is difficult to ascertain based on a
single case, this observation provides a valuable
hypothesis for future diagnostic and therapeutic
work-up. In ourpatient, onlyTSmosaicismhas turned
out to be a potentially relevant cause for epilepsy.
Caryotype evaluation should be considered in cases
of pharmaco-resistant temporal non-lesional epi-
lepsy, also including patients with late epilepsy onset
and no sign of gonadal dysfunction, in order to
determine the frequency of this association.Acknowledgements
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